OrbiMed’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-950,200
| Closed | -$41.9M | – | 120 |
|
|
2025
Q1 | $41.9M | Sell |
950,200
-304,831
| -24% | -$14M | 1.01% | 29 |
|
|
2024
Q4 | $45.3M | Sell |
1,255,031
-135,600
| -10% | -$4.74M | 0.94% | 31 |
|
|
2024
Q3 | $44.6M | Sell |
1,390,631
-316,700
| -19% | -$11.8M | 0.82% | 38 |
|
|
2024
Q2 | $64.3M | Hold |
1,707,331
| – | – | 1.28% | 22 |
|
|
2024
Q1 | $84M | Sell |
1,707,331
-1,512,028
| -47% | -$69.9M | 1.54% | 21 |
|
|
2023
Q4 | $118M | Sell |
3,219,359
-749,229
| -19% | -$19.6M | 2.35% | 10 |
|
|
2023
Q3 | $91.8M | Sell |
3,968,588
-210,000
| -5% | -$5.74M | 1.97% | 12 |
|
|
2023
Q2 | $110M | Sell |
4,178,588
-320,312
| -7% | -$8.42M | 2% | 13 |
|
|
2023
Q1 | $116M | Sell |
4,498,900
-751,100
| -14% | -$22M | 2.29% | 12 |
|
|
2022
Q4 | $137M | Sell |
5,250,000
-275,926
| -5% | -$6.8M | 2.61% | 8 |
|
|
2022
Q3 | $158K | Sell |
5,525,926
-502,381
| -8% | -$14.4M | 2.93% | 4 |
|
|
2022
Q2 | $148K | Hold |
6,028,307
| – | – | 2.7% | 7 |
|
|
2022
Q1 | $340M | Hold |
6,028,307
| – | – | 5.52% | 1 |
|
|
2021
Q4 | $374M | Hold |
6,028,307
| – | – | 4.8% | 1 |
|
|
2021
Q3 | $382M | Sell |
6,028,307
-15,959
| -0.3% | -$1.23M | 4.21% | 1 |
|
|
2021
Q2 | $498M | Sell |
6,044,266
-142,041
| -2% | -$10.8M | 5.05% | 1 |
|
|
2021
Q1 | $455M | Sell |
6,186,307
-1,220,000
| -16% | -$95.5M | 4.27% | 1 |
|
|
2020
Q4 | $537M | Hold |
7,406,307
| – | – | 4.7% | 2 |
|
|
2020
Q3 | $353M | Hold |
7,406,307
| – | – | 4.46% | 2 |
|
|
2020
Q2 | $311M | Hold |
7,406,307
| – | – | 4.4% | 1 |
|
|
2020
Q1 | $200M | Hold |
7,406,307
| – | – | 3.38% | 4 |
|
|
2019
Q4 | $285M | Hold |
7,406,307
| – | – | 4.08% | 4 |
|
|
2019
Q3 | $161M | Buy |
+7,406,307
| New | +$175M | 3.08% | 8 |
|
Other funds holding SWTX
GCL
TAL
BCM
MF
FTCM